Intermediate filament synemin acts as a regulator of cell remodelling during cardiac hypertrophy - 25/06/24
Résumé |
Introduction |
Synemin, an intermediate filament expressed in skeletal, cardiac and smooth muscle, is associated with the protein kinase A (PKA) through its tail domain, acting as an A-kinase-anchoring protein (AKAP) that regulates the spatial and temporal targeting of PKA activity. Previously we found that mechanical overload of skeletal muscle induces fiber hypertrophy in synemin-knockout mice. Moreover, two missense mutations near the AKAP domain have been identified in human patients with dilated cardiomyopathy.
Objective |
Our aim is to investigate the impact of synemin in cardiac hypertrophy by a combination of in vivo and in vitro models.
Method |
Functional, morphological and molecular analyzes were carried on cardiomyocyte-specific synemin-knockout mice (SynHKO) after 14 days of isoproterenol administration (30mg/kg/day) by Alzet mini-pumps. Moreover, we investigated the response of human SYNM-KO induced pluripotent stem cells (iPSC) – derived cardiomyocytes to stimulation with isoproterenol (10nM) or forskolin (10μM), both activators of PKA.
Results |
After isoproterenol administration, SynHKO mice exhibited increased heart weight (+14%) and cardiac cell width (+26%), significant fibrosis, and left ventricular dysfunction compared to controls. Then, we generated human SYNM-KO iPSC lines using CRISPR/Cas9 system. They are able to differentiate into beating cardiomyocytes with desmin and cardiac troponin expression. The human SYNM-KO cardiomyocytes, stimulated for 7 days with isoproterenol, exhibit an increase of their area (+52%). No noticeable effect was observed in the control group (Fig. 1). Measurements of the calcium flux and contraction kinetic 20minutes after forskolin stimulations indicated that SYNM-KO cardiac cells reached calcium and contraction peaks faster with a 24% increase of calcium decay time and beat interval compared to control cells. Finally, a variation in the phosphorylation profile of PKA targets was observed in these cardiomyocytes stimulated by forskolin.
Conclusion |
These findings suggest a crucial role of synemin in cardiac remodelling and the loss of synemin-PKA coupling could trigger these alterations.
Le texte complet de cet article est disponible en PDF.Plan
Vol 117 - N° 6-7S
P. S196 - juin 2024 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?